Sunzen Biotech Bhd (0148) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sunzen Biotech Bhd (0148) has a cash flow conversion efficiency ratio of 0.027x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM3.58 Million ≈ $897.56K USD) by net assets (RM134.42 Million ≈ $33.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sunzen Biotech Bhd - Cash Flow Conversion Efficiency Trend (2016–2023)
This chart illustrates how Sunzen Biotech Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 0148 total debt and obligations for a breakdown of total debt and financial obligations.
Sunzen Biotech Bhd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sunzen Biotech Bhd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Structural Monitoring Systems Plc
AU:SMN
|
0.187x |
|
Fuel Tech Inc
NASDAQ:FTEK
|
-0.022x |
|
Digital Currency X Technology Inc.
NASDAQ:DCX
|
0.005x |
|
InBioGen Co Ltd
KO:101140
|
-0.010x |
|
Asia Green Energy Public Company Limited
BK:AGE
|
0.113x |
|
Walkabout Resources Ltd
AU:WKT
|
-0.073x |
|
GenMont Biotech Inc
TW:3164
|
0.034x |
|
NTT System SA
WAR:NTT
|
0.057x |
Annual Cash Flow Conversion Efficiency for Sunzen Biotech Bhd (2016–2023)
The table below shows the annual cash flow conversion efficiency of Sunzen Biotech Bhd from 2016 to 2023. For the full company profile with market capitalisation and key ratios, see Sunzen Biotech Bhd market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | RM149.84 Million ≈ $37.62 Million |
RM819.39K ≈ $205.72K |
0.005x | +102.08% |
| 2022-12-31 | RM121.88 Million ≈ $30.60 Million |
RM-32.06 Million ≈ $-8.05 Million |
-0.263x | -89.88% |
| 2021-12-31 | RM118.10 Million ≈ $29.65 Million |
RM-16.36 Million ≈ $-4.11 Million |
-0.139x | -268.20% |
| 2020-12-31 | RM87.47 Million ≈ $21.96 Million |
RM7.20 Million ≈ $1.81 Million |
0.082x | +168.12% |
| 2019-12-31 | RM91.37 Million ≈ $22.94 Million |
RM-11.05 Million ≈ $-2.77 Million |
-0.121x | -217.88% |
| 2018-12-31 | RM106.94 Million ≈ $26.85 Million |
RM-4.07 Million ≈ $-1.02 Million |
-0.038x | -194.09% |
| 2017-12-31 | RM99.45 Million ≈ $24.97 Million |
RM4.02 Million ≈ $1.01 Million |
0.040x | +1434.55% |
| 2016-12-31 | RM97.23 Million ≈ $24.41 Million |
RM256.13K ≈ $64.31K |
0.003x | -- |
About Sunzen Biotech Bhd
Sunzen Group Berhad, an investment holding company, engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through Human Health, Medical Devices and Services, and Loan Financing segments. The company provides veterinary, pharmaceutical, chemical products, animal health, … Read more